Ultime notizie per Envoy Medical (NASDAQ:COCH) Azioni

Envoy Medical

Envoy Medical Inc is a hearing health company focused on providing innovative medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life.

Long Ideas

News

Penny Stocks

Insider Trades

Markets

Trading Ideas

Envoy Medical, Inc. - Class A Common Stock

COCH

HYLN

SXTP

Scopri le penny stock sotto i $5 in cui Hyliion e altri due titoli stanno attirando l&#39;attenzione degli insider.

Penny stock sotto i $5: Hyliion e altri 2 titoli sotto osservazione

Envoy Medical Inc

Cochlear Ltd

Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) shares traded higher Friday as striking employees are expected to vote on a new contract proposal on Monday, Nov. 4. Here&#8217;s<a href="https://www.benzinga.com/markets/equities/24/11/41676667/boeing-sweetens-deal-with-38-wage-hike-12k-bonus-and-more-to-end-7-week-strike-vote-set-for-mond"> what you need to know.</a>
What To Know: According to<a href="https://aviationweek.com/aerospace/manufacturing-supply-chain/boeing-machinists-reach-new-tentative-deal#:~:text=The%20new%20proposed%20deal%2C%20reached,Boeing%20and%20the%20union%20show."> Aviation Daily</a>, the company announced a tentative deal with the International Association of Machinists (IAM), potentially ending a 49-day strike. This union-recommended agreement proposes a 38% wage increase over four years—13% in the first year, followed by 9% in each of the next two years and 7% in the final year. 
Additionally, workers would receive a $12,000 ratification bonus and improved 401(k) contributions. Boeing also committed to locating any new aircraft production in the Puget Sound region of Washington, a key concession for the union.
This deal comes after union members previously rejected two offers, including a 35% wage increase in October. The initial union request included a 40% wage increase and pension restorations, but the new deal focuses on wage hikes and bonuses, while pensions remain unchanged. If approved, Boeing expects production facilities to gradually reopen as early as Nov. 6, with full staffing anticipated over the following weeks.
The strike and production delays have impacted Boeing's suppliers, with some, like Spirit AeroSystems, already implementing employee furloughs. Boeing CEO Kelly Ortberg emphasized the importance of a careful restart process, citing ongoing issues with production stability and meeting FAA safety standards.
What Else: Boeing&#8217;s rating also remains on S&amp;P&#8217;s CreditWatch following a larger-than-anticipated equity issuance, which helps offset projected cash flow deficits through 2025. However, S&amp;P noted Boeing's limited flexibility for further cash flow pressures and cited ongoing strike-related and post-strike operational risks as areas of concern.
BA Price Action: Boeing shares were up 3.5% at $154.59 on Friday, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" width="1024" height="539" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01152847/BA-1024x539.png" alt="" class="wp-image-626219" style="width:451px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01152847/BA-1024x539.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01152847/BA-300x158.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01152847/BA-768x405.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/01152847/BA.png 1441w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/24/11/41693751/biden-can-blame-boeing-for-massive-jobs-data-miss">Biden Can Blame Boeing For Massive Jobs Data Miss</a></li>
</ul>
Photo via Shutterstock.

Movers

Why Boeing Shares Traded Higher On Friday

WIIM

Sherwin-Williams shares are trading higher after it was announced that the company will join the Dow Jones Industrial Average.

NVDA

NVIDIA shares are trading higher after it was announced that the company will join the Dow Jones Industrial Average.

Offerings

RDZN

Roadzen Files For Mixed Shelf Of Up To $100M

Contracts

ITRM

Iterum Therapeutics Notified Pfizer, Electing To Defer Milestone Payment For 2 Years For ORLYNVAH, Or Until Oct 25, 2026

The Symplicity &#x2122; blood pressure procedure offers patients a new adjunct approach to lowering blood pressure&nbsp;
GALWAY, Ireland, Nov. 1, 2024 /PRNewswire/ -- Medtronic plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>), a global leader in healthcare technology, today announced that the Centers for Medicare &amp; Medicaid Services (CMS) has granted transitional pass-through (TPT) payment for the Medtronic Symplicity Spyral&#x2122;&nbsp;renal denervation (RDN) catheter, used in the Symplicity&#x2122;&nbsp;blood pressure procedure, under the Medicare Hospital Outpatient Prospective Payment System. TPT payment, which will be effective for up to three years beginning January 1, 2025, aims to support patient access to new and innovative technology, including devices granted Breakthrough Device Designations like the Symplicity Spyral RDN system.

Biotech

General

CMS grants Transitional Pass-Through Payment For Medtronic Symplicity Spyral Renal Denervation Catheter; Will Be Effective For Up To Three Years Beginning January 1, 2025

Titan International Files For Offering Of Up To 11.92M Shares By The Selling Stockholders

NioCorp Developments Ltd. ("NioCorp" or the "Company") (NASDAQ:<a href="https://www.benzinga.com/stock/NB#NASDAQ">NB</a>) today announced it has commenced a proposed underwritten public offering in the United States (the "Registered Offering"). Concurrently, the Company has also commenced a private placement (the "Private Offering" and, together with the Registered Offering, the "Offerings").
The Registered Offering consists of common shares and warrants to purchase common shares and is subject to market conditions. There can be no assurance as to whether or when the Registered Offering may be completed, or as to the actual size, pricing or other terms of the Registered Offering. In addition, the Company intends to grant the underwriter a 45-day over-allotment option to purchase up to an additional 15 percent of the number of initial common shares and/or an additional 15 percent of the number of initial warrants offered in the Registered Offering.
The Private Offering consists of common shares and warrants to purchase common shares. There can be no assurance as to whether or when the Private Offering may be completed, or as to the actual size, pricing or other terms of the Private Offering. Completion of the Private Offering is not contingent on completion of the Registered Offering and completion of the Registered Offering is not contingent on the completion of the Private Offering.
Maxim Group LLC is acting as sole book-running manager and underwriter for the Registered Offering.
NioCorp currently intends to use the net proceeds from the Offerings for working capital and general corporate purposes, including to (i) advance its efforts to launch construction of a critical minerals project in Southeast Nebraska (the "Elk Creek Project") and move it to commercial operation and (ii) repay all amounts outstanding under the Company's $2.0 million non-revolving multiple draw credit facility (the "Smith Credit Facility") available pursuant to the Loan Agreement, dated September 11, 2024, by and between the Company and its Chief Executive Officer, President and Executive Chairman, Mark Smith. The Smith Credit Facility will continue to be available to the Company following the close of the Offerings.
The Registered Offering is subject to customary closing conditions.

NioCorp Announces Commencement Of Proposed Underwritten Public Offering Of Common Shares & Warrants; No Size Or Amount Disclosed

CHWY

Chewy shares are trading higher after it was announced that the company will join the S&P MidCap 400 prior to the opening of trading on Wednesday, November 6, 2024.

<a href="https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20241101-1475162/1475162_djiadjuaintcdowaes.pdf" title="https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20241101-1475162/1475162_djiadjuaintcdowaes.pdf">https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20241101-1475162/1475162_djiadjuaintcdowaes.pdf</a>

NVIDIA And Sherwin-Williams Set To Join Dow Jones Industrial Average; Vistra To Join Dow Jones Utility Average

<a href="https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20241101-1475163/1475163_srcl4.pdf" title="https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20241101-1475163/1475163_srcl4.pdf">https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20241101-1475163/1475163_srcl4.pdf</a>

SRCL

Chewy Set to Join S&P MidCap 400; Chewy Will Replace Stericycle Inc In The S&P MidCap 400 Effective Prior To The Opening Of Trading On Wednesday, November 6

<a href="https://www.bloomberg.com/news/articles/2024-11-01/tesla-sells-499-million-of-debt-backed-by-solar-equipment-loans">https://www.bloomberg.com/news/articles/2024-11-01/tesla-sells-499-million-of-debt-backed-by-solar-equipment-loans</a>
Tesla Inc. sold $499 million of bonds backed by loans offered to customers buying solar equipment.

Financing

Asset Sales

TSLA

'Tesla Sells $499M Of Debt Backed by Solar Equipment Loans' - Bloomberg News

EVTV

Envirotech Vehicles Files Prospectus Relates To Resale, From Time To Time, Of Up To 13.6M Shares Of Common Stock

Global

BORR

Borr Drilling Limited Announces Voluntary Delisting From Oslo Stock Exchange; Co's Shares Will Be Delisted From OSE As Of 31 December 2024

ONCO

Onconetix Files For Resale Of Up To 10,586,556 Shares By The Selling Stockholders; Offering Up To 6.25M Shares Of Common Stock

- SEC Filing&nbsp;
On October 30, 2024, the Company received a letter from Nasdaq notifying the Company that, the Company had not regained compliance with the MVLS Requirement within the Cure Period. As a result, Nasdaq has determined to delist the Company's securities from Nasdaq on November 8, 2024, subject to the Company's right to appeal described below.
&nbsp;
On October 31, 2024, the Company requested a hearing to appeal such determination before a panel (the "Hearings Panel"). The hearing request will stay the suspension of the trading of the Company's common stock pending such hearing or any extension provided by the Hearings Panel.
&nbsp;
At such hearing, the Company intends to submit a plan to regain compliance with the MVLS Requirement and with other deficiencies in its compliance with Nasdaq listing requirements that have been previously disclosed, including the failure to comply with the minimum bid price requirement disclosed in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on October 25, 2024.
&nbsp;
No assurances can be provided that the Company will obtain a favorable decision from the Hearings Panel, and/or that the Company will be able to regain or maintain compliance with Nasdaq listing's rules.

CERO

CERo Therapeutics Received A Letter From Nasdaq Notifying The Company That It Had Not Regained Compliance With The MVLS Requirement Within The Cure Period; Nasdaq Has Determined To Delist The Company's Securities From Nasdaq On November 8, 2024; On October 31, 2024, The Co Requested A Hearing To Appeal The Determination Before A Panel

BNTC

Benitec Biopharma Files For Mixed Shelf Of Up To $125M

Super League Enterprise 13G Filing Shows Infinite Reality, Inc. Reported A 9.2% Stake In The Co As Of October 29, 2024

ITT Files For Mixed Shelf; Size Not Disclosed

ADAP

Adaptimmune Therapeutics Receives Nasdaq Notice For Non-Compliance With Minimum Bid Price

Northland Securities analyst Carl Byrnes maintained a Buy rating on Envoy Medical (COCH – Research Report) today and set a price target of $5.00. T...

Northland Securities Sticks to Its Buy Rating for Envoy Medical (COCH)

Edward Woo, an analyst from Ascendiant, has initiated a new Buy rating on Envoy Medical (COCH). Edward Woo has given his Buy rating due to a combin...

Envoy Medical's Innovative Cochlear Implant Sparks Buy Rating Amidst Market Growth Potential

Envoy Medical (COCH) just unveiled an announcement. Envoy Medical, Inc. is presenting its updated Investor Presentation to both existing and potent...

Envoy Medical Updates Investor Presentation with Forward-Looking Statements

Lake Street analyst Frank Takkinen maintained a Buy rating on Envoy Medical (COCH – Research Report) today and set a price target of $6.00. The com...

Lake Street Keeps Their Buy Rating on Envoy Medical (COCH)

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Envoy Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/coch-stock-quote/">COCH</a>) just reported results for the second quarter of 2024.<ul><li>Envoy Medical reported earnings per share of -27 cents. This was below the analyst estimate for EPS of -25 cents.</li><li>The company reported revenue of $68,000.</li><li>This was 17.58% worse than the analyst estimate for revenue of $82,500.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/coch-stock-earnings-envoy-medical-for-q2-of-2024/">COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q2 2024

Envoy Medical GAAP EPS of -$0.27

Envoy Medical (COCH) Receives a Buy from Lake Street

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Arcutis Biotherapeutics (ARQT – Research Report) and...

Wall Street Analysts Are Bullish on Top Healthcare Picks

Envoy Medical (COCH) announces that its Investigational Device Exemption, IDE, application for its pivotal study of the Acclaim Fully Implanted Coc...

Envoy Medical receives FDA approval to initiate study for hearing device

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Butterfly Network (BFLY – Research Report) and Envoy...

Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY) and Envoy Medical (COCH)

ARQT

BFLY

Press Releases

Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage

Earnings

Envoy Medical Reports Second Quarter 2024 Results and Provides Business Update

Envoy Medical Secures Lending Facility of $10M

Envoy Medical Awarded Patent for Recharge System used with Implantable Battery

Major Envoy Medical Investor Glen Taylor Discusses How Apple's AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company

Envoy Medical Celebrates First Anniversary Trading as a Public Company under COCH on Nasdaq Capital Market

American Medical Association Approves Groundbreaking New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Opening New Opportunities for Envoy Medical's Esteem® Device

Envoy Medical to Present at the   LD Micro Main Event XVII

Key Advocates Urge CMS to Clarify that Fully Implanted Active Middle Ear Hearing Devices are Prosthetic Devices for Purposes of Medicare Coverage

Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device

Comments

Envoy Medical

Notizie

Ultime notizie per Envoy Medical (NASDAQ:COCH) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO